Policy & Politics
GHTC Congressional Briefing Focuses on Protecting Global Health Research Investments
March 1, 2013
Writing in the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog, GHTC Communications Officer Kim Lufkin summarizes the group's annual congressional briefing, "which focused on how U.S. policymakers can protect the nation's investments in global health research in upcoming budget discussions." She writes, "As the panelists stressed, there are several compelling humanitarian reasons to protect U.S. investments in global health research," and adds the speakers "also emphasized that there are countless domestic benefits that come with U.S. investments in global health research." Lufkin includes comments from the panelists, who included Alan Magill, director of malaria at the Bill & Melinda Gates Foundation; Lisa Cohen, executive director of the Washington Global Health Alliance; and Caroline Ryan, deputy coordinator for Technical Leadership at PEPFAR (2/28).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)